Let's imagine what a deal for Apabetalone with a large BP would look like.

Let's assume we have good results in CVD and CD and we missed narrowly the CVD.

Realistically it would be possible RVX could get $5 billion USD with 15% Royalties on future sales..

That would get us to at least $30 CAD per share with a huge warehouse of other drugs.

Anh other possibilities, for the purchaseof Apabetalone...?